PG · PROCTER & GAMBLE Co

$147.38 +0.41 (+0.28%) At close · Jul 24

Market Cap

$343.26B

2.33B

Trades by corporate insiders — officers, directors and holders of more than 10% of the shares — disclosed to the SEC on Forms 3, 4 and 5. Form 4 must be filed within two business days of the trade.

Date	Insider	Role	Type	Security	Shares	Price	Value	After
2026-06-09	Kempczinski Christopher J	Director	Award↑ Filing footnotes — Common Stock (Direct) Restricted Stock Units awarded pursuant to The Procter & Gamble 2025 Stock and Incentive Compensation Plan. Total includes grant of dividend equivalents in the form of Restricted Stock Units.	Common Stock	258	—	—	11,595
2026-06-09	McCarthy Christine M	Director	Award↑ Filing footnotes — Common Stock (Direct) Restricted Stock Units awarded pursuant to The Procter & Gamble 2025 Stock and Incentive Compensation Plan. Total includes grant of dividend equivalents in the form of Restricted Stock Units.	Common Stock	253	—	—	17,512
2026-06-09	JIMENEZ JOSEPH	Director	Award↑ Filing footnotes — Common Stock (Direct) Restricted Stock Units awarded pursuant to The Procter & Gamble 2025 Stock and Incentive Compensation Plan. Total includes grant of dividend equivalents in the form of Restricted Stock Units.	Common Stock	320	—	—	37,016
2026-06-09	McEvoy Ashley	EVP, WW Chair, MedTech	Award↑ Filing footnotes — Common Stock (Direct) Restricted Stock Units awarded pursuant to The Procter & Gamble 2025 Stock and Incentive Compensation Plan. Total includes grant of dividend equivalents in the form of Restricted Stock Units.	Common Stock	202	—	—	5,986
2026-06-09	ARNOLD CRAIG	Director	Award↑ Filing footnotes — Common Stock (Direct) Restricted Stock Units awarded pursuant to The Procter & Gamble 2025 Stock and Incentive Compensation Plan. Total includes grant of dividend equivalents in the form of Restricted Stock Units.	Common Stock	202	—	—	2,807
2026-06-09	Portman Robert Jones	Director	Award↑ Filing footnotes — Common Stock (Direct) Restricted Stock Units awarded pursuant to The Procter & Gamble 2025 Stock and Incentive Compensation Plan. Total includes grant of dividend equivalents in the form of Restricted Stock Units.	Common Stock	51	—	—	5,155
2026-03-10	JIMENEZ JOSEPH	Director	Award↑ Filing footnotes — Common Stock (Direct) Restricted Stock Units awarded pursuant to The Procter & Gamble 2025 Stock and Incentive Compensation Plan. Total includes grant of dividend equivalents in the form of Restricted Stock Units.	Common Stock	273	—	—	36,512
2026-03-10	Portman Robert Jones	Director	Award↑ Filing footnotes — Common Stock (Direct) The original Form 4, filed on March 11, 2026, is being amended by this Form 4/A solely to correct an inadvertent, administrative error. The original Form 4 reported that the Reporting Person was awarded 193 Restricted Stock Units ("RSUs" ) pursuant to The Procter & Gamble 2025 Stock and Incentive Compensation Plan. However, as reported in this amended form, the Reporting Person was awarded 49 RSUs. No other changes have been made to the original filing.	Common Stock	49	—	—	5,065
2026-03-10	Kempczinski Christopher J	Director	Award↑ Filing footnotes — Common Stock (Direct) Restricted Stock Units awarded pursuant to The Procter & Gamble 2025 Stock and Incentive Compensation Plan. Total includes grant of dividend equivalents in the form of Restricted Stock Units.	Common Stock	201	—	—	11,251
2026-03-10	McCarthy Christine M	Director	Award↑ Filing footnotes — Common Stock (Direct) Restricted Stock Units awarded pursuant to The Procter & Gamble 2025 Stock and Incentive Compensation Plan. Total includes grant of dividend equivalents in the form of Restricted Stock Units.	Common Stock	209	—	—	17,128
2026-03-10	McEvoy Ashley	EVP, WW Chair, MedTech	Award↑ Filing footnotes — Common Stock (Direct) Restricted Stock Units awarded pursuant to The Procter & Gamble 2025 Stock and Incentive Compensation Plan. Total includes grant of dividend equivalents in the form of Restricted Stock Units.	Common Stock	161	—	—	5,751
2026-03-10	ARNOLD CRAIG	Director	Award↑ Filing footnotes — Common Stock (Direct) Restricted Stock Units awarded pursuant to The Procter & Gamble 2025 Stock and Incentive Compensation Plan. Total includes grant of dividend equivalents in the form of Restricted Stock Units.	Common Stock	161	—	—	2,586
2026-02-27	Francisco Ma. Fatima	CEO - Baby, Fem & Family Care	Sell↓	Common Stock	120	$165.31	$19,837	1,078
2026-02-27	Francisco Ma. Fatima	CEO - Baby, Fem & Family Care	Sell↓	Common Stock	50	$165.32	$8,266	1,028
2026-02-27	Francisco Ma. Fatima	CEO - Baby, Fem & Family Care	Sell↓ Filing footnotes — Common Stock (Direct) Total includes grant of dividend equivalents in the form of Restricted Stock Units (RSU's) settled in common stock.	Common Stock	5,249	$165.29	$867,607	1,328
2026-02-27	Francisco Ma. Fatima	CEO - Baby, Fem & Family Care	Sell↓	Common Stock	130	$165.30	$21,489	1,198
2026-02-19	Whaley Susan Street	Chief Legal Officer & Secy	Sell↓ Filing footnotes — Common Stock (Direct) Total includes grant of dividend equivalents in the form of Restricted Stock Units (RSU's) settled in common stock.	Common Stock	1,809	$159.46	$288,454	30,215
2026-02-17	Francisco Ma. Fatima	CEO - Baby, Fem & Family Care	Award↑ Filing footnotes — Restricted Stock Units (Direct) Dividend equivalents in the form of Restricted Stock Units (RSUs) previously awarded pursuant to issuer's retirement program. All such RSUs represent a contingent right to receive Procter & Gamble common stock. These units will deliver in shares on retirement from the company, unless delivery is deferred or such shares are contributed to reporting person's deferred compensation account.	Restricted Stock Units	57	—	—	888
2026-02-17	Whaley Susan Street	Chief Legal Officer & Secy	Award↑ Filing footnotes — Restricted Stock Units (Direct) Dividend equivalents in the form of Restricted Stock Units (RSUs) previously awarded pursuant to issuer's retirement program. All such RSUs represent a contingent right to receive Procter & Gamble common stock. These units will deliver in shares on retirement from the company, unless delivery is deferred or such shares are contributed to reporting person's deferred compensation account.	Restricted Stock Units	11	—	—	65
2026-02-13	Aguilar Moses Victor Javier	Chf Rsch, Dev & Innov Officer	Sell↓ Filing footnotes — Common Stock (Direct) Weighted average price of the shares sold. The price range was $162.26 to $162.311. Full information regarding the number of shares sold at each separate price available upon request.	Common Stock	15,169	$162.28	$2,461,609	44,735
2026-02-13	Aguilar Moses Victor Javier	Chf Rsch, Dev & Innov Officer	Convert↑	Common Stock	15,169	$91.07	$1,381,441	59,904
2026-02-13	Aguilar Moses Victor Javier	Chf Rsch, Dev & Innov Officer	Convert↓	Stock Option (Right to Buy)	15,169	—	—	0
2026-02-12	Moeller Jon R	Director	Convert↓	Stock Option (Right to Buy)	162,232	—	—	0
2026-02-12	Moeller Jon R	Director	Convert↑	Common Stock	162,232	$113.23	$18,369,529	481,616
2026-02-12	Moeller Jon R	Director	Sell↓ Filing footnotes — Common Stock (Direct) Weighted average price of the shares sold. The price range was $162.13 to $162.65. Full information regarding the number of shares sold at each separate price available upon request.	Common Stock	162,232	$162.45	$26,354,361	319,384
2026-02-12	Coombe Gary A	CEO - Grooming	Convert↓	Stock Option (Right to Buy)	36,093	—	—	36,093
2026-02-12	Coombe Gary A	CEO - Grooming	Convert↑ Filing footnotes — Common Stock (Direct) Total includes grant of dividend equivalents in the form of Restricted Stock Units (RSU's) settled in common stock. Total includes grant of dividend equivalents in the form of Restricted Stock Units (RSU's) and shares acquired through the issuer's dividend reinvestment plan.	Common Stock	36,093	$78.52	$2,834,022	71,086
2026-02-12	Coombe Gary A	CEO - Grooming	Sell↓ Filing footnotes — Common Stock (Direct) Weighted average price of the shares sold. The price range was $162.33 to $162.35. Full information regarding the number of shares sold at each separate price available upon request.	Common Stock	36,093	$162.33	$5,859,002	34,993
2026-02-11	Purushothaman Balaji	Chief Human Resources Officer	Sell↓ Filing footnotes — Common Stock (Direct) Weighted average price of the shares sold. The price range was $160.30 to $160.36. Full information regarding the number of shares sold at each separate price available upon request.	Common Stock	12,827	$160.31	$2,056,287	12,638
2026-02-11	Moeller Jon R	Director	Convert↑	Common Stock	11,036	$113.23	$1,249,606	330,420
2026-02-11	Purushothaman Balaji	Chief Human Resources Officer	Convert↑	Common Stock	12,827	$91.07	$1,168,155	25,465
2026-02-11	Purushothaman Balaji	Chief Human Resources Officer	Convert↓	Stock Option (Right to Buy)	12,827	—	—	0
2026-02-11	Moeller Jon R	Director	Convert↓	Stock Option (Right to Buy)	11,036	—	—	162,232
2026-02-11	Moeller Jon R	Director	Sell↓	Common Stock	11,036	$160.00	$1,765,760	319,384
2026-02-04	Francisco Ma. Fatima	CEO - Baby, Fem & Family Care	Sell↓	Common Stock	8,000	$158.00	$1,264,000	6,571
2026-01-23	Pritchard Marc S.	Chief Brand Officer	Convert↓	Stock Option (Right to Buy)	95,903	—	—	0
2026-01-23	Pritchard Marc S.	Chief Brand Officer	Convert↑	Common Stock	95,903	$80.29	$7,700,052	278,509
2026-01-23	Pritchard Marc S.	Chief Brand Officer	Sell↓ Filing footnotes — Common Stock (Direct) Weighted average price of the shares sold. The price range was $150.36 to $151.60. Full information regarding the number of shares sold at each separate price available upon request.	Common Stock	95,903	$151.15	$14,495,690	182,606
2025-12-09	McCarthy Christine M	Director	Award↑ Filing footnotes — Common Stock (Direct) Restricted Stock Units awarded pursuant to The Procter & Gamble 2025 Stock and Incentive Compensation Plan. Total includes grant of dividend equivalents in the form of Restricted Stock Units.	Common Stock	269	—	—	16,808
2025-12-09	ARNOLD CRAIG	Director	Award↑ Filing footnotes — Common Stock (Direct) Restricted Stock Units awarded pursuant to The Procter & Gamble 2025 Stock and Incentive Compensation Plan. Total includes grant of dividend equivalents in the form of Restricted Stock Units.	Common Stock	215	—	—	2,409
2025-12-09	JIMENEZ JOSEPH	Director	Award↑ Filing footnotes — Common Stock (Direct) Restricted Stock Units awarded pursuant to The Procter & Gamble 2025 Stock and Incentive Compensation Plan. Total includes grant of dividend equivalents in the form of Restricted Stock Units.	Common Stock	341	—	—	36,083
2025-12-09	McEvoy Ashley	EVP, WW Chair, MedTech	Award↑ Filing footnotes — Common Stock (Direct) Common Stock awarded pursuant to The Procter & Gamble 2025 Stock and Incentive Compensation Plan. Total includes grant of dividend equivalents in the form of Restricted Stock Units.	Common Stock	215	—	—	5,562
2025-12-09	Kempczinski Christopher J	Director	Award↑ Filing footnotes — Common Stock (Direct) Restricted Stock Units awarded pursuant to The Procter & Gamble 2025 Stock and Incentive Compensation Plan. Total includes grant of dividend equivalents in the form of Restricted Stock Units	Common Stock	260	—	—	10,978
2025-12-09	Portman Robert Jones	Director	Award↑ Filing footnotes — Common Stock (Direct) Restricted Stock Units awarded pursuant to The Procter & Gamble 2025 Stock and Incentive Compensation Plan. Total includes grant of dividend equivalents in the form of Restricted Stock Units.	Common Stock	54	—	—	4,983
2025-12-03	Davis Jennifer L.	Director	Tax↓ Filing footnotes — Common Stock (Direct) Shares withheld to cover taxes on previous Restricted Stock Unit grant.	Common Stock	60	$144.35	$8,661	61,768
2025-12-03	Moeller Jon R	Director	Convert↓ Filing footnotes — Restricted Stock Units (Direct) Retirement award in the form of Restricted Stock Units which represent a contingent right to receive P&G common stock or cash settlement. Amount and price computed per benefit formula for plan year ended 6/30/2025. These units will deliver in shares on retirement from the company, unless delivery is deferred or such shares are contributed to reporting person's deferred compensation account.	Restricted Stock Units	159	—	—	2,083
2025-12-03	Pritchard Marc S.	Chief Brand Officer	Convert↑ Filing footnotes — Common Stock (Direct) Total includes grant of dividend equivalents in the form of Restricted Stock Units (RSU's) settled in common stock.	Common Stock	94	$144.35	$13,569	182,701
2025-12-03	Raman Sundar G.	CEO-Fabric & Home Care	Convert↓ Filing footnotes — Restricted Stock Units (Direct) Retirement award in the form of Restricted Stock Units which represent a contingent right to receive P&G common stock or cash settlement. Amount and price computed per benefit formula for plan year ended 6/30/2025. These units will deliver in shares on retirement from the company, unless delivery is deferred or such shares are contributed to reporting person's deferred compensation account.	Restricted Stock Units	59	—	—	995
2025-12-03	Francisco Ma. Fatima	CEO - Baby, Fem & Family Care	Convert↑ Filing footnotes — Common Stock (Direct) Total includes grant of dividend equivalents in the form of Restricted Stock Units (RSU's) settled in common stock.	Common Stock	73	$144.35	$10,538	14,644
2025-12-03	Whaley Susan Street	Chief Legal Officer & Secy	Convert↓ Filing footnotes — Restricted Stock Units (Direct) Retirement award in the form of Restricted Stock Units which represent a contingent right to receive P&G common stock or cash settlement. Amount and price computed per benefit formula for plan year ended 6/30/2025. These units will deliver in shares on retirement from the company, unless delivery is deferred or such shares are contributed to reporting person's deferred compensation account.	Restricted Stock Units	54	—	—	717

Legend Buy — open-market purchase Sell — open-market sale ↑ Shares acquired ↓ Shares disposed (gift, conversion, tax…)

Showing 1–50 of 2,018 transactions

Key facts CIK 80424 CUSIP 742718109 13F (30d) 1420 filings 1382 filers Visit website Investor relations